With regard to drug products currently awaiting approval and market authorization by Health Canada: (a) what is the complete list of products currently awaiting approval; (b) for each product in (a), what was the (i) date the application was received by the government, (ii) manufacturer, (iii) product name, (iv) summary of product claims, including the list of diseases and conditions the product claims to treat, (v) expected date of decision of approval by Health Canada, if known; and (c) has the time period between the date of application and the decision date by Health Canada, for non-COVID-19 related products increased as a result of reallocating resources during the pandemic, and, if so, what are the specific details, including for which applications and for which products the time period has increased?
In the House of Commons on November 18th, 2020. See this statement in context.